Andrew J. Irving

7.0k total citations · 1 hit paper
78 papers, 5.8k citations indexed

About

Andrew J. Irving is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Andrew J. Irving has authored 78 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cellular and Molecular Neuroscience, 32 papers in Molecular Biology and 27 papers in Pharmacology. Recurrent topics in Andrew J. Irving's work include Neuroscience and Neuropharmacology Research (31 papers), Cannabis and Cannabinoid Research (26 papers) and Receptor Mechanisms and Signaling (22 papers). Andrew J. Irving is often cited by papers focused on Neuroscience and Neuropharmacology Research (31 papers), Cannabis and Cannabinoid Research (26 papers) and Receptor Mechanisms and Signaling (22 papers). Andrew J. Irving collaborates with scholars based in United Kingdom, Ireland and United States. Andrew J. Irving's co-authors include Jenni Harvey, Graham L. Collingridge, Ruth A. Ross, Lynne Shanley, David E. Jane, Dervla O’Malley, Christopher N. Connolly, Sharon Anavi‐Goffer, Christopher M. Henstridge and Jeffrey C. Watkins and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Andrew J. Irving

76 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors

1993 621 citations Andrew J. Irving, Jeremy M. Henley et al. profile →

Peers

Countries citing papers authored by Andrew J. Irving

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Irving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Irving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Irving more than expected).

Fields of papers citing papers by Andrew J. Irving

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Irving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Irving. The network helps show where Andrew J. Irving may publish in the future.

Co-authorship network of co-authors of Andrew J. Irving

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Irving. A scholar is included among the top collaborators of Andrew J. Irving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Irving. Andrew J. Irving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GPR18, GPR55 and GPR119 in GtoPdb v.2023.1 2023 ·IUPHAR/BPS Guide to Pharmacology CITE ·S P H Alexander, Andrew J. Irving	1
2	G-protein coupled estrogen receptor (GPER1) activation promotes synaptic insertion of AMPA receptors and induction of chemical LTP at hippocampal temporoammonic-CA1 synapses 2023 ·Molecular Brain ·(unknown), (unknown), (unknown), Andrew J. Irving, Jenni Harvey	6
3	Novel putative ligands of cannabinoid receptors: synthesis and effects on cell signaling and neuronal functions 2023 ·SHILAP Revista de lepidopterología ·(unknown), Anna Kryshchyshyn‐Dylevych, (unknown), Monika Wujec, Rostyslav Stoika, Andrew J. Irving, Roman Lesyk	1
4	GPR18, GPR55 and GPR119 (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database 2019 ·IUPHAR/BPS Guide to Pharmacology CITE ·S P H Alexander, Andrew J. Irving	2
5	Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors 2017 ·Advances in pharmacology ·Andrew J. Irving, (unknown), Sue Chan, (unknown), Jenni Harvey, S P H Alexander	61
6	Emerging roles for the novel estrogen-sensing receptor GPER1 in the CNS 2016 ·Neuropharmacology ·Amy E. Alexander, Andrew J. Irving, Jenni Harvey	67
7	Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB ₂ receptor agonists: identifying novel GPR55 inhibitors 2016 ·Journal of Basic and Clinical Physiology and Pharmacology ·Sharon Anavi‐Goffer, Andrew J. Irving, Ruth A. Ross	6
8	Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists 2015 ·European Journal of Medicinal Chemistry ·(unknown), Teija Parkkari, Dina Navia‐Paldanius, Tuomo Laitinen, Agnieszka A. Kaczor, Tarja Kokkola, (unknown), Juha R. Savinainen, Jarmo T. Laitinen, Antti Poso, (unknown), (unknown), (unknown), (unknown), Andrew J. Irving, Tapio Nevalainen	20
9	Leptin Induces a Novel Form of NMDA Receptor-Dependent LTP at Hippocampal Temporoammonic-CA1 Synapses 2015 ·eNeuro ·Xiao Luo, (unknown), Andrew J. Irving, Jenni Harvey	40
10	Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling 2014 ·Journal of Biological Chemistry ·Estefanía Moreno, Clara Andradas, Mireia Medrano, María M. Caffarel, Eduardo Pérez-Gómez, Sandra Blasco-Benito, María Gómez‐Cañas, M. Ruth Pazos, Andrew J. Irving, Carme Lluı́s, Enric I. Canela, Javier Fernández‐Ruíz, Manuel Guzmán, Peter J. McCormick, Cristina Sánchez	89
11	Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids 2011 ·Journal of Biological Chemistry ·Sharon Anavi‐Goffer, Gemma L. Baillie, Andrew J. Irving, Jürg Gertsch, Iain R. Greig, Roger G. Pertwee, Ruth A. Ross	129
12	Differential trafficking of adenosine receptors in hippocampal neurons monitored using GFP- and super-ecliptic pHluorin-tagged receptors 2011 ·Neuropharmacology ·(unknown), Sônia A. L. Corrêa, Andrew J. Irving, Bruno G. Frenguelli	10
13	GPR55 ligands promote receptor coupling to multiple signalling pathways 2010 ·British Journal of Pharmacology ·Christopher M. Henstridge, Nariman Balenga, R Schröder, Julia Kargl, Wolfgang Platzer, Lene Martini, J. Simon C. Arthur, (unknown), Jennifer L. Whistler, Evi Kostenis, Maria Waldhoer, Andrew J. Irving	171
14	A role for L‐α‐lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells 2010 ·British Journal of Pharmacology ·(unknown), Anke J. Roelofs, Sharon Anavi‐Goffer, (unknown), (unknown), Andrew J. Irving, Michael J. Rogers, Ann M. Rajnicek, Ruth A. Ross	117
15	Characterization of the effects of four HTR3B polymorphisms on human 5-HT3AB receptor expression and signalling 2008 ·Pharmacogenetics and Genomics ·Karen Krzywkowski, Paul Davies, Andrew J. Irving, Hans Bräuner‐Osborne, Anders A. Jensen	7
16	An Essential Role for Constitutive Endocytosis, but Not Activity, in the Axonal Targeting of the CB1 Cannabinoid Receptor 2006 ·Molecular Pharmacology ·Neil McDonald, Christopher M. Henstridge, Christopher N. Connolly, Andrew J. Irving	73
17	Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception 2001 ·Neuropharmacology ·Ruth A. Ross, Angela A. Coutts, Shona M. McFarlane, Sharon Anavi‐Goffer, Andrew J. Irving, Roger G. Pertwee, David J. MacEwan, Roderick H. Scott	147
18	Proceedings of the Ernst Schering research foundation workshop series 1997 ·Springer US ·Andrew J. Doherty, Andrew J. Irving, Graham L. Collingridge, Jeremy M. Henley	1
19	Activation of the NO-cGMP signalling pathway depresses hippocampal synaptic transmission through an adenosine receptor-dependent mechanism 1994 ·Neuropharmacology ·Matthew R. Broome, Graham L. Collingridge, Andrew J. Irving	45
20	A gabbro-troctolite-anorthosite intrusion at Dirnaseer, near Temora, New South Wales 1972 ·Journal and proceedings of the Royal Society of New South Wales ·P. M. Ashley, Andrew J. Irving	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact